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Thrombosis of the axillary or subclavian vein
(SCV) occurs infrequently. There are a number of
causes of secondary SCV thrombosis.1 The manage-
ment of the underlying cause or condition along
with anticoagulation therapy/thrombolysis and arm
elevation are the cornerstones of the treatment.
Primary or effort thrombosis of the SCV (Paget-
Schroetter syndrome) generally develops in healthy
individuals after acute or repetitive exertion or after
unusual positioning of the upper extremity. In the
current era, the management of SCV effort throm-
bosis is variable and controversial. The unresolved
issues include the indications and the timing of oper-
ative or transcatheter intervention after successful
thrombolysis. The basic treatment often is limited to
anticoagulation therapy and elevation, which result
in early symptom reduction in most patients.
However, the disabling symptoms recur in 33% to
85% of the patients on return to normal activity, and
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Background: There is considerable variability and controversy in the current management
of subclavian-vein effort thrombosis. The purpose of this study was to determine the
long-term effectiveness and the functional outcome of our preferred treatment strategy of
early thrombolysis/recanalization and prompt extensive supraclavicular decompression.
Patients and methods: Thirty-three patients who ranged in age from 15 to 60 years
underwent operative decompression of 34 primary subclavian-vein thromboses, one of
which was bilateral. There were 21 patients with acute thrombosis—7 of whom had had
prior unsuccessful balloon venoplasty, 1 with stent placement—and 8 patients with
chronic/recurrent thrombosis—5 of whom had had 9 unsuccessful prior operations for
attempted decompression. Four patients had high-grade symptomatic stenosis and posi-
tional occlusion. A supraclavicular approach was used in 32 cases and, in 23 cases, was
complemented by an infraclavicular (n = 21) or transaxillary (n = 2) incision. Complete
subclavian-vein decompression was achieved by first-rib resection (n = 31), scalenecto-
my (n = 33), and circumferential venolysis (n = 34).
Results: Follow-up was obtained in 30 patients at a mean of 31 months. Twenty of the
21 patients with acute thrombosis had a complete resolution of symptoms with a return
to full activity; the other patient was lost to follow-up. Four of the 8 patients with
chronic thrombosis reported a mild relief of symptoms but still had limitations of activ-
ities of daily living. All of the patients with high-grade symptomatic stenosis with posi-
tional occlusion had a complete relief of symptoms and a return to full activity. 
Conclusion: The optimal management of acute effort thrombosis of the subclavian vein
includes anticoagulation therapy, thrombolysis/recanalization, confirmatory positional
venography, and early supraclavicular decompression of the subclavian vein. In the
patients with chronic subclavian-vein thrombosis and positional venographic evidence of
compression of first-rib bypass graft collaterals, the initial anticoagulation therapy
should be followed by the surgical decompression of the collaterals. The supraclavicular
approach alone or with an infraclavicular incision provides optimal exposure for
scalenectomy, total first-rib resection, and circumferential venolysis. (J Vasc Surg
1998;28:777-86.)
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pulmonary embolism or venous gangrene of the
hand will develop in a small percentage of the
patients.2-8
The potential for improving the long-term func-
tional outcomes in patients with SCV thrombosis
requires the early reestablishment of venous patency
and the prevention of recurrent thrombosis and its
sequelae. These principles have been incorporated into
the management approach to this condition, initially
with operative thrombectomy and subsequently with
thoracic outlet decompression by claviculectomy,
scalenectomy, or first-rib resection.1-6,8-11 The advent
of thrombolytic therapy with streptokinase or uroki-
nase (Abbokinase, Abbott Laboratories, North
Chicago, Ill) has obviated the need for early thrombec-
tomy. The complete recanalization of the SCV now
can be achieved in a high percentage of the cases.8,12
However, there is a significant risk of rethrombosis and
of recurrence of symptoms.10,11,13-15 Positional
venography, by showing the costoclavicular compres-
sion of the SCV on the abduction and external rota-
tion of the upper extremity, can help identify the
patients who are at a risk for such an event and who
may benefit from operative decompression (Fig 1).
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Fig 1. A, Normal anatomy of costoclavicular region during upper extremity adduction, 
B, with oblique parasagittal cross-section through normal costoclavicular space at the level of
anterior scalene muscle. Subclavian vein passes between clavicle and subclavius muscle antero-
superiorly, first rib inferiorly, and anterior scalene muscle posteriorly. Subclavius muscle runs
anterior to subclavian vein and inserts medially on head of first rib. In adduction, subclavian
vein is not compressed. C, Normal anatomy of costoclavicular region during upper extremity
abduction, D, with oblique parasagittal cross-section through costoclavicular space, as
described above. Anterior scalene muscle is contracted, pulling first rib superiorly. Subclavius
muscle also is contracted. As a result, costoclavicular space is narrowed. m, Muscle; v, vein.
We have reviewed our experience with SCV
effort thrombosis with costoclavicular venous com-
pression defined by positional venography. We, 
like others, believe that the patients with Paget-
Schroetter syndrome should undergo early SCV
thrombolysis/recanalization followed by surgical
decompression.8-11 In this report, we present our
experience with this treatment strategy, with an
emphasis on the versatility of the supraclavicular
operative approach and on the durable restoration of
normal or improved venous circulation in the affect-
ed limb that this approach provides.
PATIENTS AND METHODS
Patients. The records of all the patients with
venous thoracic outlet syndrome who underwent
operative decompression from 1977 to 1997 were
examined retrospectively. The patients with sec-
ondary SCV thrombosis were not included in the
study. The inpatient and outpatient records were
reviewed for information regarding patient demo-
graphics, clinical presentation, previous local surgery
(thoracic outlet decompression), venographic find-
ings, surgical approach and technique, perioperative
complications, postoperative venography, and long-
term outcome.
Thirty-three patients (21 male, 12 female), who
ranged from 15 to 60 years in age (median, 30
years), were seen with a history of 34 SCV throm-
boses (26 right, 8 left), which were treated with
operative decompression. The first 6 patients in this
series were described in an earlier report.1 All of the
patients were seen with pain, swelling, or cyanosis of
the upper extremity. The symptoms produced vary-
ing degrees of reduction in function or in use of the
affected arm or a limitation in the activities of daily
living. Two patients had pulmonary embolism, 1
had factor V Leiden mutation, 4 had associated neu-
rogenic thoracic outlet syndrome on the basis of the
history and the brachial plexus tension testing, and
2 had associated arterial thoracic outlet syndrome
(hand ischemia).
The assessment of SCV patency and the confir-
mation of the diagnosis was achieved with supine
positional venography (adduction, arm at side;
abduction, arm at ~90-degree abduction and full
external rotation) in 32 extremities, with duplex
scanning in 1, and with intraoperative assessment in
another. Nine of the 19 patients who had bilateral
positional venography had normal-appearing con-
tralateral SCVs in the resting position that were
occluded but asymptomatic on 90-degree abduc-
tion. One of the patients with asymptomatic con-
tralateral positional SCV occlusion underwent pro-
phylactic decompression.
All of the patients with evidence of thrombosis
initially underwent anticoagulation therapy. The
patients were classified as having either: 1, acute
SCV thrombosis (evidence of thrombosis on venog-
raphy and symptoms for <2 weeks; n = 21); 2,
chronic/recurrent SCV thrombosis (n = 8); 3, high-
grade symptomatic SCV stenosis (n = 4); or 4,
asymptomatic/contralateral SCV stenosis with posi-
tional occlusion (n = 9; 1 patient underwent opera-
tion). The demographic and diagnostic features of
the groups are summarized in Table I.
Acute subclavian-vein thrombosis (Fig 2, A).
Of the 21 patients with acute thrombosis, after
1992, 17 patients underwent preoperative lytic ther-
apy with urokinase infusion and were recanalized
(patent SCV). The lytic therapy consisted of a
catheter-directed urokinase infusion into the throm-
bus at a dose of 100,000 to 250,000 units/hour for
24 to 72 hours. In the remaining 4 patients, venous
patency was reestablished with preoperative antico-
agulation therapy with heparin/coumadin (n = 2; 3-
day overlap; international normalized ratio, 1.5 to
2.5) or with operative thrombectomy (n = 2). After
the recanalization, all of the 21 patients showed
positional occlusion of the SCV at the level of the
first rib on the preoperative venography. The surgery
typically was performed within 1 week of the throm-
bolysis. Seven of the 21 patients with acute throm-
bosis had prior unsuccessful percutaneous translumi-
nal angioplasty, including 1 patient who had con-
comitant stenting (Fig 3). 
Chronic/recurrent subclavian-vein thrombo-
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Table I. Demographic and diagnostic variables
No. Median age 
of in years Affected Contralateral
Patient group patients (range) extremity stenosis*
Acute 21 26 (15 to 60) R = 14, 6
L = 7
Chronic 8 32 (26 to 56) R = 7, 2
L = 1
High-grade 4 49 (36 to 51) R = 4 1
symptomatic
stenosis
Asymptomatic 1 36 R = 1
contralateral
positional 
occlusion
Total 34 30 (15 to 60) R = 26, 9
L = 8
R, Right; L, left.
*Contralateral occlusion on positional venography.
sis (Fig 2, B). Chronic or recurrent thrombosis was
seen in 8 patients, 5 of whom had had 9 prior oper-
ative decompressions (1 to 6 years previously),
which had failed to provide symptomatic relief (Fig
2, C). The prior operations included transaxillary
partial first-rib resection (n = 5), pectoralis minor
release (n = 2), interposition saphenous vein grafting
(n = 1), and intraoperative venous thrombectomy
with dilatation (n = 1). Of the 8 patients with chron-
ic/recurrent SCV thrombosis, 7 showed extensive
venous collaterals that bypassed the first rib, which
were compressed during positional venography. 
High-grade symptomatic stenosis. In 4
patients, the venography showed prethrombotic
high-grade stenosis with positional occlusion during
90-degree abduction. The symptoms included pain
and swelling with the activities of daily living.
Asymptomatic positional occlusion. Nine
patients had an asymptomatic high-grade stenosis of
the contralateral SCV that was detected during the
positional venography. One of these patients under-
went prophylactic decompression.
Operative techniques. Thirty-four operations
were performed on these 33 patients. The supraclav-
icular approach was used in 32 cases and was supple-
mented by an infraclavicular incision in 21 cases (par-
aclavicular approach) or a transaxillary approach in 2
cases. The need for an infraclavicular incision was
determined during surgery when a complete first-rib
resection to the costosternal junction could not be
achieved via the supraclavicular approach alone. This
was typically in the patients with an SCV that was
located caudad to the clavicle, in which case an infra-
clavicular incision facilitated the division of the cos-
toclavicular ligament and subclavius muscle and the
division of the medial first rib. The transaxillary
approach, without supraclavicular incision, was used
in 2 patients, 1 of which was supplemented by an
infraclavicular incision. Complete thoracic outlet
decompression was achieved with first-rib resection
(n = 31), scalenectomy (n = 33), and circumferential
venolysis (n = 34). In 1 patient, a jugular SCV bypass
graft was required because of a prior failed balloon
angioplasty and stent, which damaged the SCV. Two
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Fig 2. Cross-sections through costoclavicular space during abduction, as described in Fig 1.
A, Patient with acute subclavian-vein thrombosis after thrombolytic recanalization.
Costoclavicular space is narrowed abnormally, and subclavian vein undergoes compressive occlu-
sion. There is perivenous fibrosis and inflammation of vein wall. This recapitulates prethrom-
botic state. B, Patient with chronic subclavian-vein occlusion. Prominent first-rib bypass graft
collaterals are compressed on abduction. C, After transaxillary first-rib resection, there is unre-
sected medial portion of first rib, which, during abduction, contributes to subclavian-vein com-
pression, perivenous adventitial inflammation and fibrosis, and risk of subsequent thrombosis.
D, After supraclavicular resection of anterior scalene, subclavius, and entire first rib with cir-
cumferential venolysis, costoclavicular space is effectively decompressed. m, Muscle; v, vein.
patients with significant residual stenosis and intralu-
minal clot underwent thrombectomy and vein patch
angioplasty. In the patients with chronic/recurrent
SCV thrombosis, the first-rib bypass graft collaterals
were identified and carefully preserved. The bypass
graft collaterals that were critical to preserve are those
that provided reentry into the jugular-subclavian
venous system through the cephalic system and those
that were typically perivenous (SCV), periclavicular,
or coursing through the scalene fat pad. The specific
veins that served as important collaterals included
principally the external jugular, the subscapular, the
suprascapular, and the cephalic veins and the arcus
venosus jugularis and the angulus venosus. These
veins were preserved by taking care not to divide or
ligate them during mobilization of the scalene fat pad
and circumferential venolysis.
Assessment of outcomes. The outcomes were
determined with postoperative venography that was
obtained 1 week to 3 months after operation and with
serial outpatient follow-up visits or telephone inter-
views. The outcomes were categorized as good, fair,
or poor, and defined as follows: a good outcome con-
sisted of the resolution of symptoms (a return to full
premorbid activity) and of a widely patent SCV on the
positional venography. A fair outcome consisted of an
improvement in symptoms (exertional limitation) and
of unimpaired SCV or collateral venous flow on the
positional venography. A poor outcome consisted of
no change in the symptoms or an exacerbation there-
of and persistent SCV thrombosis with compromised
collateral flow on venography.
RESULTS
Operative findings. A total of 33 patients had
34 thoracic outlet decompressions. In addition to
SCV compression between the head of the clavicle
and the first rib, a variety of factors that caused SCV
compression or that predisposed to thrombosis were
found during surgery. These factors are summarized
in Table II. 
Perioperative outcome. There were no perioper-
ative deaths. Three patients required postoperative
exploration: 1 each for bleeding, lymphatic leak, or
SCV thrombosis. There were 2 transient nerve injuries
(cervical roots 5 to 6, phrenic). Twenty-six patients
underwent postoperative venography, between 1 week
and 3 months after surgery. All of the patients in the
acute group had relief of positional compression of
recanalized SCVs (Fig 4). In 4 patients, the mild to
moderate residual SCV stenosis was treated with post-
operative percutaneous balloon dilatation. The residual
stenoses were deemed significant on the basis of sub-
jective determination of decreased flow or abnormal
contour on real-time postoperative venograms. The
specific criteria that we used as the indications for veno-
plasty were luminal diameter reduction to less than
50% on adduction or marked residual flow through
collaterals. A brisk, improved flow was seen after per-
cutaneous venoplasty in this group (Fig 5). In the
group of patients with chronic SCV thrombosis, symp-
tomatic relief occurred in patients with patent first-rib
bypass graft collaterals on positional venography. 
Intermediate or long-term outcome. The fol-
low-up period averaged 31 months and ranged from
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Fig 3. Preoperative venogram in patient with acute
thrombosis recanalized with lytic therapy. Subclavian-vein
stenosis here was treated with percutaneous balloon
angioplasty and stent placement. Note kinking of stent
between clavicle and first rib, and note mural thrombus
formation.
Table II. Intraoperative pathologic findings that
cause subclavian-vein compression/thrombosis*
First time operations
Perivenous fibrosis
Hypertrophic or fibrotic subclavius muscle
Large/prominent scalene tubercle
Broad interdigitating insertion of hypertrophic scalene
Fibrocartilaginous bands
Endoluminal synechiae
Reoperations
Perivenous fibrosis
Incompletely resected first rib
Broad interdigitating insertion of hypertrophic scalene
Unresected scalene musculature
Reattachment of partially resected scalene to scar in first-
rib bed
*In addition to the usual finding of subclavian-vein compression
between the head of the clavicle and the first rib, which was seen
in all patients.
2 months to 20 years. Three patients were lost to
follow-up. The outcomes are summarized in Table
III. Twenty of the 21 patients with acute SCV
thrombosis had a complete resolution of symptoms
with a return to full activity (good outcome). One
patient was lost to follow-up. All 4 of the patients
with high-grade symptomatic stenosis of the SCV
with positional occlusion had a complete relief of
symptoms with a return to full activity and no post-
operative sequelae. Four of the 8 patients with
chronic/recurrent SCV thrombosis reported some
improvement in symptoms but still had limitations
of activities of daily living (fair outcome). Two
patients were lost to follow-up. In another 2
patients, there was no improvement in the symp-
toms (poor outcome). Both patients had underwent
multiple previous attempts at decompression or
reconstruction. Of the 9 patients with high-grade
asymptomatic stenosis and positional occlusion of
the contralateral SCV, 1 had prophylactic supraclav-
icular decompression without complications. All of
the 9 patients have been free from symptoms in the
contralateral upper extremity at follow-up, which
ranged from 4 months to 6 years (median, 18
months).
DISCUSSION
Paget16 and von Schroetter17 have been credited
with the description of a syndrome, which carries
their names, in which spontaneous venous thrombo-
sis of the upper extremity occurs in otherwise healthy
individuals. In 1875, Paget16 reported 2 cases of rel-
atively young men who were seen with arm edema,
weakness, and prominent superficial veins. He
termed the clinical condition “gouty phlebitis” and
attributed it to primary thrombosis of the axillo-
SCVs. Nine years later, von Schroetter17 reported a
similar case and postulated a similar cause. The sub-
sequent reports used terms that conferred a causal
basis for the thrombotic event and included “trau-
matic,” “strain,” or “effort” thrombosis. The first
suggestion that effort is a cause of thrombosis is
dated as early as 1849 by Professor Ranzi of Pisa.13
In the early 20th century, many authors cited axillo-
subclavian compression during exercise or unusual
positioning by the musculoskeletal components of
the thoracic outlet and the costoclavicular space.
Venous injury, it was proposed, occurred after acute
or repetitive venous compression between the first
rib, anterior scalene muscle and tubercle, and the
clavicle with underlying subclavius muscle and
fibrous costocoracoid ligament.13-15
Historically, the treatment in most cases involved
arm rest and elevation and occasionally the addition
of anticoagulants. Hughes,13 in an extensive review,
tabulated all of the reported cases of primary throm-
bosis of the SCV up to 1949. Of the 320 cases,
about 20% of the patients who were treated with
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Fig 4. A, Preoperative acute thrombosis of right subcla-
vian vein followed by recanalization. On abduction, there
is positional compression of subclavian vein. B and C,
After operative decompression, subclavian vein is widely
patent on adduction and shows improvement on abduc-
tion relative to preoperative state.
rest, elevation, or anticoagulation therapy had per-
sistent symptoms and some degree of disability. In
approximately another 20%, only a partial recovery
was reported. Pulmonary embolism was reported in
3 patients (1%). 
Tilney and colleagues7 reported on the natural
history of upper extremity venous thrombosis as a
result of primary (effort) or secondary (trauma, sys-
temic disease, thrombophlebitis) causes in 48
patients. Nonoperative management was used in all
of the patients, and more than half of the patients
underwent anticoagulation therapy. About 75% of
the patients with effort thrombosis had a residual
disability at an average of 6.6 years later. In other
follow-up studies, persistent sequelae and impair-
ment has been observed in a significant number of
the patients. 
Adams et al2-4 reported 23 patients with Paget
Schroetter syndrome who underwent a conservative
treatment. Pulmonary embolism occurred in 10% of
the patients, and venous gangrene of the hand devel-
oped in 1 patient. Residual disability was present in
almost 70% of the cases. The frequency of poor out-
comes prompted the authors to perform an urgent
venous thrombectomy to relieve the obstruction.
Claviculectomy was added to relieve the venous
compression between the first rib and the clavicle,
and to prevent reinjury and recurrent thrombosis.
The authors reported improved outcomes with this
approach.
Thrombolytic therapy has proven to be an effec-
tive treatment method in the reestablishment of
venous patency after upper extremity venous throm-
bosis and has obviated the need for urgent
thrombectomy. This therapy is most effective within
the first week after thrombosis and may rarely be
successful 2 to 4 weeks after the development of
symptoms. Both urokinase and streptokinase have
been shown to be effective.8,10-12,18 Local urokinase
infusion into the thrombotic segment is preferred
because of its effectiveness (>90% success rates) and
its avoidance of systemic effects and allergic reac-
tions. After clot lysis, positional venography, with
the abduction of the affected arm, confirms SCV
compression, which suggests that the SCV remains
at a risk for reinjury and recurrent thrombosis. Thus,
thrombolysis alone is inadequate for the definitive
management of primary SCV thrombosis when
severe positional obstruction is shown.1,8-10 The
extrinsic compressive elements within the costoclav-
icular space are best removed surgically to reduce the
threat of rethrombosis.
Recurrent thrombosis has been documented in
one third of the patients when the underlying abnor-
mality is not corrected surgically.11 Percutaneous bal-
loon venoplasty is not effective in the relief of the
venous compression or in the prevention of venous
thrombosis. In our series, 7 patients underwent percu-
taneous balloon venoplasty that failed before referral
for surgery, which included 1 with supplementary
stenting that caused injury to the vein (Fig 3). This
patient required the reconstruction of the SCV by
jugular-subclavian bypass grafting to treat the stent-
injured vein. Preoperative percutaneous venoplasty
also fails to relieve venous stenosis after recanalization
and may in fact increase the risk of subsequent
rethrombosis. Machleder10 reports that SCV rethrom-
bosis occurred principally in the patients who had pre-
operative balloon venoplasty to relieve extrinsic com-
pression that was interpreted as “stricture” of the SCV.
The rate of SCV rethrombosis after preoperative bal-
loon venoplasty was 58%. Machleder’s algorithm for
the management of SCV thrombosis includes recanal-
ization with lytic therapy (urokinase), followed by anti-
coagulation therapy for 3 months and reevalution. If
the symptoms persist or if there is venographic evi-
dence of compression of the SCV or its collaterals,
then transaxillary first-rib resection is recommended.
The results of decompression were excellent for the
patients with both a patent SCV (90% asymptomatic)
and residual venous thrombosis (>80% asymptomatic).
There were no episodes of recurrent thrombosis.
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Table III. Operative outcome by diagnostic group
Outcome*
Patient group Good Fair Poor Lost to follow-up
Acute 20 0 0 1
Chronic 0 4 2 2
High-grade symptomatic stenosis 4 0 0 0
Asymptomatic contralateral positional occlusion 1 0 0 0
*Outcome categories are defined in the text.
Follow-up was obtained at a mean of 31 months after surgery (2 months to 20 years).
On the basis of a 25-year experience with 67
patients, Urschel and Razzuk8 recommend thrombol-
ysis followed by early surgical decompression with
transaxillary first-rib resection in patients with primary
SCV thrombosis. Before 1980, 34 patients underwent
routine anticoagulation therapy. In 25 extremities, the
symptoms either recurred or were only partially
relieved. Twenty-one patients required transaxillary
first-rib resection, 8 with thrombectomy. On long-
term follow-up, 25 patients had a fair or poor out-
come. These discouraging results prompted the
authors to use thrombolysis and transaxillary first-rib
resection in the next 33 patients. The long-term fol-
low-up revealed a good outcome in 31 patients, with
no recurrences and only 2 patients who had persistent
symptoms.
Our review shows the results of immediate
recanalization with local urokinase infusion and with
prompt operative decompression in patients with
acute SCV thrombosis or symptomatic high-grade
(prethrombotic) stenosis. Over 90% of the patients
in these clinical categories have complete relief of
symptoms and durable venous patency on positional
venography. However, we prefer the supraclavicular
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Fig 5. A, This is left subclavian vein during positional venography in a patient with acute sub-
clavian-vein thrombosis. Subclavian vein is compressed and completely occluded. B, After cos-
toclavicular decompression for acute thrombosis, with first-rib resection, scalenectomy, and cir-
cumferential venolysis via the supraclavicular approach, there is residual stenosis as a result of
stricture. C, Balloon venoplasty in decompressed costoclavicular space yields resolution of
residual stricture.
approach to the SCV, thoracic outlet, and costoclav-
icular space. It provides excellent exposure, which
allows the accurate identification of the specific com-
pressive elements and decompression with complete
removal of the first rib along with the scalene and
subclavius musculature, along with complete cir-
cumferential venolysis (Fig 2, D). The simple divi-
sion of the scalene and subclavius muscles or of the
surrounding fibrous structures frequently results in
an inadequate thoracic outlet decompression. We
prefer to resect the first rib to the costosternal junc-
tion so that the part of the rib that underlies the
SCV is removed completely. In 2 patients with
recurrent thrombosis, we found residual first-rib
remnant or an incompletely resected and reattached
scalene musculature that compressed the vein, which
occurred after a transaxillary first-rib resection else-
where (Fig 2, C). In another patient who had under-
gone a prior failed transaxillary first-rib resection,
the anterior scalene muscle was reattached to the
scarred bed of the resected first rib, which caused the
distortion of the SCV and symptomatic thrombosis.
In 68% of the operations, we used an infraclavicular
incision to complement the exposure and to facili-
tate the resection of the rib and subclavius muscle
and circumferential venolysis. This is generally nec-
essary in patients with a low-lying SCV (located cau-
dad to the clavicle), in which case a supraclavicular
incision alone may not allow the division of the cos-
toclavicular ligament, subclavius muscle, and medial
first rib.
Molina reported thrombolytic therapy followed
by immediate operative decompression through an
infraclavicular (or subclavicular) incision, with vein
patching when a fibrotic stricture was identified.9
Although the infraclavicular approach offers ade-
quate exposure of the SCV and the costoclavicular
space, the supraclavicular approach facilitates the
complete removal of the first rib. Augmentation
patch venoplasty may be useful in certain cases, and
we used this technique twice in patients with a stric-
ture of the SCV and residual thrombus after com-
plete venolysis. Alternatively, we have used percuta-
neous venoplasty to relieve any residual venous
stenosis after complete thoracic outlet decompres-
sion. Once the costoclavicular space has been
decompressed, balloon angioplasty can be effective
in the restoration of the normal SCV contour. Thus,
although balloon venoplasty has little to offer the
patients with preoperative dynamic compression of
the SCV in the costoclavicular space, it is effective
for the selective management of residual postopera-
tive SCV stenosis (Fig 5).
In summary, primary (effort) SCV thrombosis
can be effectively recanalized with urokinase, and
the compressive factors can be relieved with supra-
clavicular or paraclavicular first-rib resection, anteri-
or and middle scalenectomy, and circumferential
venolysis. Long-term freedom from rethrombosis is
achieved in more than 90% of the patients, with no
requirement for anticoagulation therapy. The
patients with symptomatic SCV stenosis without
thrombosis have the same outcome. Chronic SCV
thrombosis with or without a prior failed operation
cannot be successfully recanalized, but if positional
venography shows compression of the first-rib
bypass graft collaterals, then supraclavicular thoracic
outlet and costoclavicular decompression reduces
but does not completely relieve the symptoms of
venous congestion. The symptoms were resolved in
the 1 patient with acute SCV thrombosis who
underwent jugular-SCV bypass grafting as a result of
SCV injury with a stent, and this may be an alterna-
tive approach in select patients with chronic throm-
bosis. However, on the basis of our experience, we
believe that there are no especially good surgical
options for the patients with chronic thrombosis.
Rather, the most effective means for the improve-
ment of the outcomes of such patients is likely to be
the increased awareness that chronic thrombosis is
difficult to manage and the recommendation of ear-
lier referral for surgical management. Prophylactic
decompression in patients with prethrombotic
lesions, which has been described in several prior
reports,8,19-21 appears attractive, but there is not suf-
ficient experience reported in the literature or in this
study to offer guidelines. However, the fact that all
8 of the patients who did not undergo operative
decompression for asymptomatic high-grade steno-
sis of the contralateral SCV have been symptom-free
for an average of 18 months suggests that prophy-
lactic intervention may not be necessary. 
The authors are grateful for the support of Abbott
Laboratories (North Chicago, Ill) through an educational
grant that was administered by the Pacific Vascular
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